HIV incidence among repeat HIV testers at a county hospital, San Francisco, California, U.S.A.

Journal of Acquired Immune Deficiency Syndromes

Volumn 28, Issue 1, 2001, Pages 59-64

  Kellogg, Timothy A ^a,e   McFarland, Willi ^a   Perlman, Jennifer L ^b   Weinstock, Hillard ^d   Bock, Stephanie ^d   Katz, Mitchell H ^a   Gerberding, Julie L ^c   Bangsberg, David R ^b  

^a Department of Public Health ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

HIV incidence; Hospitals; Injection drug use; San Francisco; Sentinel surveillance

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CORRELATION FUNCTION; DATA BASE; FEMALE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SEROCONVERSION; STATISTICAL ANALYSIS; UNITED STATES; VIRUS TRANSMISSION; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; NONBIOLOGICAL MODEL; SERODIAGNOSIS;

AIDS SERODIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HOSPITALS, COUNTY; HUMAN; INCIDENCE; PROPORTIONAL HAZARDS MODELS; SAN FRANCISCO; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035454921     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200109010-00009     Document Type: Article

References (25)

1. Low estimates of HIV seroconversions among clients of a drug treatment clinic in San Francisco, 1995 to 1998
2. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver
3. High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaire: Estimating incidence from serial seroprevalence data
4. Decreasing prevalence hides a high HIV incidence: Miami
5. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand
6. HIV seroincidence and risk factors among repeatedly tested for HIV attending sexually transmitted clinics in the United States, 1991 to 1996
7. HIV incidence among repeat HIV testers with sexually transmitted diseases in Italy
8. Incidence of HIV infection in homosexual men attending a sexually transmitted disease clinic in London by a novel unlinked anonymous method
9. The PHREG procedure
10. HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic
11. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk factor analysis
12. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes
13. Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco
14. Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City
15. Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency
16. Young and recent injecting drug users are at higher risk for HIV
17. Viral infections in short-term drug users: The prevalence of hepatitis C, hepatitis B, human immunodeficiency virus, and human T-lymphotrophic viruses
18. Correlates of HIV infection among young adult short-term injection drug users
19. Increasing HIV incidence among MSM repeat testers in Ontario, Canada, 1992-1998
20. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings and technical guidance on HIV counseling